Peak Planning Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Peak Planning Group's ABBV Position: Q2 2026 in Review
Peak Planning Group increased its AbbVie (ABBV) stake by 0.03% in Q2 2026, buying an estimated $215 and bringing the position to 3,487 shares worth $877K. The position accounts for 0.2% of the portfolio, ranked #56.
Peak Planning Group first reported a position in ABBV in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.03M in Q1 2023. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Peak Planning Group held 3,487 shares of AbbVie worth $877K as of Q2 2026.
- Peak Planning Group bought 1 AbbVie share in Q2 2026, an estimated $215.
- AbbVie made up 0.2% of Peak Planning Group's portfolio in Q2 2026, its #56 holding.
- Peak Planning Group first reported a position in AbbVie in Q3 2020 and has held it in 20 quarters since.
- Peak Planning Group's AbbVie position peaked at $1.03M in Q1 2023.
- 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Peak Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.